Mandate

Vinge advised LumenRadio AB (publ) in connection with the listing on Nasdaq First North Growth Market

Vinge has advised LumenRadio AB (publ) (“LumenRadio”) in connection with its listing on Nasdaq First North Growth Market. The prospectus was published on 28 November 2022 and the first day of trading occurred on 8 December 2022.

The offering in connection with the listing was conducted at a fixed price of SEK 48 per share, corresponding to a market value for LumenRadio’s shares of approximately SEK 544 million before the offering and approximately SEK 594 million after the completion of the offering.

LumenRadio is a Gothenburg based technology company focusing on developing and selling reliable wireless product-to-product connections for business-critical applications within the Internet of Things (“IoT”). LumenRadio offers scalable solutions that build on proprietary and patented technology for future-proof wireless data transfer on open frequency bands, replacing traditional cables for control and automation. LumenRadio has around 60 employees and is headquartered in Gothenburg, with two small sales offices in Frankfurt and Boston.

Vinge’s team primarily consisted of Magnus Pauli, Edin Agic (Project Manager), Petronella Hallberg, Adrian Filipovic, Amelia Rihs, Hanna Jansson (Capital Markets and Public M&A), Anna Högsten, Victoria Gunnerek (Employment and Sanctions) and Amanda Stoltz (VDR).

 

Related

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025

Vinge advises Advania in connection with the acquisition of atNorth HPC AB

Vinge has advised Advania, one of the leading IT companies in the Nordic region, in connection with the acquisition of atNorth HPC AB. The acquisition strengthens Advania's presence within high-performance computing (HPC).
October 03, 2025